Anita R. Iskandar
      OUR PEOPLE

      Dr. Anita Iskandar

      PhD in Biochemical and Molecular Nutrition

      Head - SFP Product Safety

      Contact

      Anita is Head of Product Safety for Smoke-Free Products, and in this role, she leads the Product Safety team, leveraging her extensive scientific background to contribute to the nonclinical assessment of smoke-free products.  

      Anita has spent more than a decade at PMI and has expertise in risk assessment, product testing, and assessment strategies. Anita also holds the DABT (Diplomate American Board of Toxicology) certification, demonstrating her qualifications in the field of toxicology. 

      Anita's scientific interests focus on molecular biology and nutrition. Before joining PMI, Anita carried out research at the Nutrition and Cancer Biology Lab and also completed a postdoctoral fellowship at the USDA Jean Mayer Human Nutrition Research Center on Aging, which is part of Tufts University, in Boston, Massachusetts. 

      She earned her PhD in Biochemical and Molecular Nutrition from The Gerald J. and Dorothy R. Friedman School of Nutrition Science and Policy at Tufts University. Additionally, she is currently pursuing an MSc in Toxicology for Human Risk Assessment from the Johns Hopkins Bloomberg School of Public Health.  

      Latest Publications

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
      ​
      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.